Jason S. Knight, Ph.D.
Affiliations: | 2005 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Microbiology Biology, Virology BiologyGoogle:
"Jason Knight"Parents
Sign in to add mentor| Erle S. Robertson | grad student | 2005 | University of Michigan | |
| (Targeted regulation of cell cycle proteins by Epstein -Barr virus nuclear antigen 3C.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Knight JS, Lan K, Subramanian C, et al. (2021) Correction for Knight et al., "Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines". Journal of Virology. 95: e0076521 |
| Zuo Y, Yalavarthi S, Gockman K, et al. (2020) Anti-NET antibodies and impaired NET degradation in antiphospholipid syndrome. Arthritis & Rheumatology (Hoboken, N.J.) |
| Zuo Y, Yalavarthi S, Shi H, et al. (2020) Neutrophil extracellular traps in COVID-19. Jci Insight |
| Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. (2020) Targeting potential drivers of COVID-19: Neutrophil extracellular traps. The Journal of Experimental Medicine. 217 |
| Zuo Y, Shi H, Li C, et al. (2020) Antiphospholipid syndrome: a clinical perspective. Chinese Medical Journal |
| Weerappuli PD, Louttit C, Kojima T, et al. (2019) Extracellular Trap-Mimicking DNA-Histone Mesostructures Synergistically Activate Dendritic Cells. Advanced Healthcare Materials. e1900926 |
| Sule G, Kelley WJ, Gockman K, et al. (2019) Increased adhesive potential of antiphospholipid syndrome neutrophils mediated by beta-2 integrin Mac-1. Arthritis & Rheumatology (Hoboken, N.J.) |
| Ali RA, Gandhi AA, Meng H, et al. (2019) Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nature Communications. 10: 1916 |
| Liu Y, Carmona-Rivera C, Moore E, et al. (2018) Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis. Frontiers in Immunology. 9: 1680 |
| Knight JS, Meng H, Coit P, et al. (2017) Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target. Jci Insight. 2 |